Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Avenue Therapeutics, Inc. (ATXI) had Stock-Based Compensation of $0.67M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.71M |
|
-- |
|
-- |
|
$0.75M |
|
$-0.75M |
|
$0.03M |
|
$-0.73M |
|
$-0.73M |
|
$-0.73M |
|
$-0.73M |
|
$-0.73M |
|
$-0.73M |
|
$-0.75M |
|
$-0.75M |
|
3.13M |
|
3.13M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$2.93M |
|
-- |
|
-- |
|
$2.93M |
|
$1.10M |
|
-- |
|
-- |
|
$1.10M |
|
$1.83M |
|
$1.83M |
|
$1.83M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-1.83M |
|
-- |
|
$2.09M |
|
$2.59M |
|
$2.85M |
|
$0.26M |
|
|
Stock-Based Compensation |
$0.67M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.63% |
|
-39.63% |
|
-24.77% |
|
-39.63% |
|
$0.58 |
|
$-0.59 |
|
$-0.59 |
|